These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2069414)

  • 1. Soluble interleukin-2 receptors and psoriasis.
    Dummer R; Dunkel FG
    Arch Dermatol Res; 1991; 283(2):138-9. PubMed ID: 2069414
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.
    Takematsu H; Tagami H
    Arch Dermatol Res; 1990; 282(3):149-52. PubMed ID: 2114831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin.
    Søndergaard K; Stengaard-Pedersen K; Zachariae H; Heickendorff L; Deleuran M; Deleuran B
    Br J Rheumatol; 1998 Mar; 37(3):304-10. PubMed ID: 9566672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia.
    Abanmi A; Al Harthi F; Al Agla R; Khan HA; Tariq M
    Int J Dermatol; 2005 Jan; 44(1):82-3. PubMed ID: 15663670
    [No Abstract]   [Full Text] [Related]  

  • 5. Does the basal lamina contain interleukin 2 receptors? Observations in emerging psoriasis vulgaris lesions.
    Laub R; Fiebig H; Wohlrab W; Taube KM
    Dermatol Monatsschr; 1988; 174(6):308-11. PubMed ID: 3264794
    [No Abstract]   [Full Text] [Related]  

  • 6. High levels of hyaluronate in suction blister fluid from active psoriatic lesions.
    Lundin A; Engström-Laurent A; Michaëlsson G; Tengblad A
    Br J Dermatol; 1987 Mar; 116(3):335-40. PubMed ID: 3567072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating hyaluronate in psoriasis.
    Lundin A; Engström-Laurent A; Hällgren R; Michaëlsson G
    Br J Dermatol; 1985 Jun; 112(6):663-71. PubMed ID: 4005166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The functional properties of interleukins in psoriasis].
    Kozin VM; Adamenko GP; Bogdanovich LI; Iakirevich EV
    Vestn Dermatol Venerol; 1989; (7):61-4. PubMed ID: 2530721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.
    Zalewska A; Głowacka E; Wyczółkowska J; Tchórzewski H; Narbutt J; Sysa-Jedrzejowska A
    Mediators Inflamm; 2006; 2006(1):81767. PubMed ID: 16864908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
    Kapp A; Neuner P; Krutmann J; Luger TA; Schöpf E
    Acta Derm Venereol; 1991; 71(5):403-6. PubMed ID: 1684468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neopterin, immune activation, and psoriasis.
    de Rie MA; Hamerlinck F; Bos JD
    Lancet; 1991 Nov; 338(8776):1208. PubMed ID: 1682616
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of UVB plus tar therapy on serum levels of interleukin-2 receptors in patients with psoriasis.
    Betti R; Rosti A; Lodi A; Bencini PL; Paparelli S; Gazzola GB; Cori P; Moroni GA; Crosti C
    Clin Exp Dermatol; 1991 Sep; 16(5):364-6. PubMed ID: 1794191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
    De Rie MA; Zonneveld IM; Witkamp L; Van Lier RA; Out TA; Bos JD
    Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis.
    Schopf RE; Dobmeyer J; Dobmeyer T; Morsches B
    Dermatology; 1993; 186(1):45-9. PubMed ID: 7679593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 and interleukin-6 in psoriasis.
    Prens EP; Benne K; van Damme J; Bakkus M; Brakel K; Benner R; van Joost T
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):121S-124S. PubMed ID: 2258628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin level is significantly elevated in lesional skin of patients with psoriasis.
    El-Khateeb EA; Zuel-Fakkar NM; Eid SM; Abdul-Wahab SE
    Int J Dermatol; 2011 Jun; 50(6):693-6. PubMed ID: 21595663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1-beta, interleukin-6, and interferon-gamma in suction blister fluids of involved and uninolved skin and in sera of psoriatic patients.
    Bonifati C; Ameglio F; Carducci M; Sacerdoti G; Pietravalle M; Fazio M
    Acta Derm Venereol Suppl (Stockh); 1994; 186():23-4. PubMed ID: 8073828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A levels in suction-blister fluid of patients with psoriasis treated systemically.
    Meinardi MM; Van Eendenburg JP; Oosting J; Van Boxtel CJ; De Rie MA; Bos JD
    Br J Dermatol; 1990 May; 122(5):671-6. PubMed ID: 2354118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis.
    de Rie MA; Hamerlinck F; Hintzen RQ; Bos JD; van Lier RA
    Arch Dermatol Res; 1991; 283(8):533-4. PubMed ID: 1664714
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetical studies on cyclosporin A in psoriasis.
    Meinardi MM; van Boxtel CJ; Oosting J; Dos JD
    Acta Derm Venereol Suppl (Stockh); 1989; 146():164. PubMed ID: 2532845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.